Back to RAPP
GOLDMAN SACHS GROUP INC → RAPP
GOLDMAN SACHS GROUP INC RAPP Position History
Rapport Therapeutics, Inc. • Healthcare
Quarters held
11
Latest value
$52M
Q2 2026
Peak value
$69.3M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $14M |
| Q3 2025 | $48.5M |
| Q3 2025 | $23.4M |
| Q4 2025 | $36.4M |
| Q4 2025 | $54.7M |
| Q4 2025 | $54.7M |
| Q4 2025 | $36.4M |
| Q1 2026 | $52.6M |
| Q1 2026 | $39.5M |
| Q2 2026 | $69.3M |
| Q2 2026 | $52M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $52M | 1.25M | — | — |
| Q2 2026 | $69.3M | 1.66M | — | — |
| Q1 2026 | $39.5M | 1.26M | — | — |
| Q1 2026 | $52.6M | 1.68M | — | — |
| Q4 2025 | $36.4M | 1.20M | — | — |
| Q4 2025 | $54.7M | 1.80M | — | — |
| Q4 2025 | $54.7M | 1.80M | — | — |
| Q4 2025 | $36.4M | 1.20M | — | — |
| Q3 2025 | $23.4M | 789.5K | — | — |
| Q3 2025 | $48.5M | 1.63M | — | — |
| Q2 2025 | $14M | 1.24M | — | — |
Other funds holding RAPP
$74.4M
$55.8M
$54.1M
$54.1M